Methoxyflavone derivatives modulate the effect of TRAIL-induced apoptosis in human leukemic cell lines

Journal of Hematology and Oncology

Volumn 4, Issue , 2011, Pages

  Wudtiwai, Benjawan ^a   Sripanidkulchai, Bungorn ^b   Kongtawelert, Prachya ^a   Banjerdpongchai, Ratana ^a  

^a Faculty of Medicine Chiang Mai University   (Thailand)

^b KHON KAEN UNIVERSITY   (Thailand)

Author keywords

apoptosis; death receptor; human leukemic cells; methoxyflavone derivatives; mitochondrial pathway; TRAIL

Indexed keywords

3,3' DIHEXYLOXACARBOCYANINE; 3,5,7,3',4' PENTAMETHOXYFLAVONE; 5,7 DIMETHOXYFLAVONE; 5,7,4' TRIMETHOXYFLAVONE; ACTIN; CASPASE 3; CASPASE 8; DEATH RECEPTOR 4; DEATH RECEPTOR 5; DICHLORODIHYDROFLUORESCEIN DIACETATE; FLAVONE DERIVATIVE; FLAVONOID; FLICE INHIBITORY PROTEIN; FLUORESCEIN ISOTHIOCYANATE; LIPOCORTIN 5; PROPIDIUM IODIDE; PROTEIN BAX; PROTEIN BID; PROTEIN MCL 1; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DOWN REGULATION; DRUG EFFECT; ENZYME ACTIVATION; ENZYME ACTIVITY; FLOW CYTOMETRY; FLUORESCENCE; HUMAN; HUMAN CELL; IC 50; LEUKEMIA CELL; MEASUREMENT; MITOCHONDRIAL MEMBRANE POTENTIAL; OUTCOME ASSESSMENT; OXIDATIVE STRESS; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN EXPRESSION; RHIZOME; UPREGULATION; WESTERN BLOTTING; ACUTE LYMPHOBLASTIC LEUKEMIA; CELL MEMBRANE POTENTIAL; CELL STRAIN U937; CULTURE TECHNIQUE; DRUG INTERACTION; ISOLATION AND PURIFICATION; LEUKEMIA; METABOLISM; MITOCHONDRION; PATHOLOGY; TUMOR CELL LINE;

APOPTOSIS; CELL CULTURE TECHNIQUES; CELL LINE, TUMOR; DRUG INTERACTIONS; FLAVONES; HUMANS; LEUKEMIA; MEMBRANE POTENTIALS; MITOCHONDRIA; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; TNF-RELATED APOPTOSIS-INDUCING LIGAND; U937 CELLS;

EID: 83755173700     PISSN: None     EISSN: 17568722     Source Type: Journal    
DOI: 10.1186/1756-8722-4-52     Document Type: Article

References (21)

1. Apoptosis control by death and decoy receptors. Ashkenazi A, Dixit VM, Curr Opin Cell Biol 1999 11 255 260 10.1016/S0955-0674(99)80034-9 10209153 (Pubitemid 29164042)
2. TRAIL and apoptosis induction by TNF-family death receptors. Wang S, El-Deiry WS, Oncogene 2003 22 8628 8633 10.1038/sj.onc.1207232 14634624 (Pubitemid 38019198)
3. Ex vivo purging of leukemia cells using tumor-necrosis-factor-related apoptosis-inducing ligand in hematopoietic stem cell transplantation. Lee NS, Cheong HJ, Kim SJ, Kim SE, Kim CK, Lee KT, Park SK, Baick SH, Hong DS, Park HS, Won JH, Leukemia 2003 17 1375 1383 10.1038/sj.leu.2402960 12835727 (Pubitemid 36857346)
4. Cancer chemopreventive properties of orally bioavailable flavonoids - methylated versus unmethylated flavones. Walle T, Ta N, Kawamori T, Wen X, Tsuji PA, Walle UK, Biochem Pharmacol 2007 73 1288 1296 10.1016/j.bcp.2006.12.028 17250812 (Pubitemid 46452585)
5. Bioactive flavonoids from Kaempferia parviflora. Yenjai C, Prasanphen K, Daodee S, Wongpanich V, Kittakoop P, Fitoterapia 2004 75 89 92 10.1016/j.fitote.2003.08.017 14693228 (Pubitemid 38010412)
6. Simultaneous identification and quantitation of 11 flavonoid constituents in Kaempferia parviflora by gas chromatography. Sutthanut K, Sripanidkulchai B, Yenjai C, Jay M, J Chromatogr A 2007 1143 227 233 10.1016/j.chroma.2007.01.033 17266972 (Pubitemid 46209121)
7. Antagonism of aryl hydrocarbon receptor signaling by 6,2',4'- trimethoxyflavone. Murray IA, Flaveny CA, DiNatale BC, Chairo CR, Schroeder JC, Kusnadi A, Perdew GH, J Pharmacol Exp Ther 2010 332 135 144 10.1124/jpet.109. 158261 19828881
8. A Dihydroxy-pentamethoxyflavone from Gardenia obtusifolia suppresses proliferation and promotes apoptosis of tumor cells through modulation of multiple cell signaling pathways. Phromnoi K, Reuter S, Sung B, Limtrakul P, Aggarwal BB, Anticancer Res 2010 30 3599 3610 20944143
9. Dihydroflavonol BB-1, an extract of natural plant Blumea balsamifera, abrogates TRAIL resistance in leukemia cells. Hasegawa H, Yamada Y, Komiyama K, Hayashi M, Ishibashi M, Yoshida T, Sakai T, Koyano T, Kam TS, Murata K, Sugahara K, Tsuruda K, Akamatsu N, Tsukasaki K, Masuda M, Takasu N, Kamihira S, Blood 2006 107 679 688 10.1182/blood-2005-05-1982 16195335 (Pubitemid 43076394)
10. Comparison in in vitro growth-inhibitory activity of carboplatin and cisplatin on leukemic cells and hematopoietic progenitors: the myelosuppressive activity of carboplatin may be greater than its antileukemic effect. Su WC, Chang SL, Chen TY, Chen JS, Tsao CJ, Jpn J Clin Oncol 2002 30 562 567
11. Curcumin sensitizes tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis through reactive oxygen species-mediated upregulation of death receptor 5 (DR5). Jung EM, Lim JH, Lee TJ, Park JW, Choi KS, Kwon TK, Carcinogenesis 2005 26 1905 1913 10.1093/carcin/bgi167 15987718 (Pubitemid 41631263)
12. Zerumbone enhances TRAIL-induced apoptosis through the induction of death receptors in human colon cancer cells: Evidence for an essential role of reactive oxygen species. Yodkeeree S, Sung B, Limtrakul P, Aggarwal BB, Cancer Res 2009 69 6581 6589 10.1158/0008-5472.CAN-09-1161 19654295
13. TRAIL receptor signalling and modulation: Are we on the right TRAIL? Mahalingam D, Szegezdi E, Keane M, de Jong S, Samali A, Cancer Treat Rev 2009 35 280 288 10.1016/j.ctrv.2008.11.006 19117685
14. Targeting death receptors in cancer with Apo2L/TRAIL. Kelley SK, Ashkenazi A, Curr Opin Pharmacol 2004 4 333 339 10.1016/j.coph.2004.02.006 15251125 (Pubitemid 38987058)
15. Simultaneous activation of the intrinsic and extrinsic pathways by histone deacetylase (HDAC) inhibitors and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) synergistically induces mitochondrial damage and apoptosis in human leukemia cells. Rosato RR, Almenara JA, Dai Y, Grant S, Mol Cancer Ther 2003 2 1273 1284 14707268
16. Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl. Martin SJ, Reutelingsperger CP, McGahon AJ, Rader JA, van Schie RC, LaFace DM, Green DR, J Exp Med 1995 182 1545 1556 10.1084/jem.182.5.1545 7595224
17. Ionizing radiation sensitizes leukemic MOLT-4 cells to TRAIL-induced apoptosis. Rezácová M, Vávrová J, Vokurková D, Acta Medica 2008 51 101 105 18998361
18. BH3-only proteins in control: specificity regulates MCL-1 and BAK-mediated apoptosis. Gélinas C, White E, Genes Dev 2005 19 1263 1268 10.1101/gad.1326205 15937216 (Pubitemid 41003016)
19. Mcl-1 interacts with truncated Bid and inhibits its induction of cytochrome c release and its role in receptor-mediated apoptosis. Clohessy JG, Zhuang J, de Boer J, Gil-Gámez G, Brady HJ, J Biol Chem 2006 281 5750 5759 16380381 (Pubitemid 43847674)
20. Molecular definitions of cell death subroutines: recommendations of the nomenclature committee on cell death 2012. Galluzzi L, Vitale I, Abrams JM, Alnemri ES, Baehrecke EH, Blagosklonny MV, et al. Cell Death Differ 2012 19 107 120 10.1038/cdd.2011.96 21760595
21. cFLIP regulation of lymphocyte activation and development. Budd RC, Yeh WC, Tschopp J, Nat Rev Immunol 2006 6 196 204 10.1038/nri1787 16498450 (Pubitemid 43290989)